HPV vaccine: Gardasil 9 approved for use in women and men aged 27 through 45 years

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to include women and men aged 27 through 45 years. Gardasil 9 prevents certain cancers and diseases caused by the nine HPV types covered by the vaccine. "Today's ["]

The post HPV vaccine: Gardasil 9 approved for use in women and men aged 27 through 45 years appeared first on Outbreak News Today.